Fig. 5
Kaplan–Meier curves for progression-free survival (PFS) (A) and overall survival (OS) (B) of all 33 patients. MTT, molecular targeted therapy; CRT, chemoradiotherapy
Fig. 5 | BMC Genomics
Kaplan–Meier curves for progression-free survival (PFS) (A) and overall survival (OS) (B) of all 33 patients. MTT, molecular targeted therapy; CRT, chemoradiotherapy